Yu Z, Shen W, Lou G, Li Y, et al. Authors' Reply to the Letter on "Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First-Line Helicobacter pylori Eradication Treatment More Effective? A Three-Arm, Multicent Helicobacter 2025;30:e70049.
PMID: 40471865